NRC

NRC

USD

National Research Corporation Common Stock (Delaware)

$14.700+0.360 (2.510%)

Echtzeitkurs

Healthcare
Health Information Services
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$14.340

Hoch

$14.775

Tief

$14.135

Volumen

0.01M

Unternehmensfundamentaldaten

Marktkapitalisierung

333.1M

Branche

Health Information Services

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.10M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $9.755Aktuell $14.700Hoch $21.64

KI-Analysebericht

Zuletzt aktualisiert: 3. Nov. 2025
KI-generiertDatenquelle: Yahoo Finance, Bloomberg, SEC

NRC Stock Update: National Research Corp Shows Volatile Recovery Pattern

Price Movement Summary

  • Recent Close: $13.43 (Nov 3) after bouncing from $11.28 low (Oct 10)
  • 3-Month Range: $11.28 - $16.14 (-30% peak-to-trough)
  • Key Catalyst: October 28 surge (+16% on 273k volume - 2.7x average)

Breaking Down the Action

  1. August Strength Steady climb from $12.58 to $16.03 (27% gain) on average volume, peaking Sept 9.

  2. September Breakdown Sharp 31% collapse from $16.03 to $11.48 over six weeks, accelerated by high-volume selling Sept 19 (-6.9%) and Sept 29 (-6.2%).

  3. October Rebound October 28 explosion ($11.43→$13.25) marked strongest single-day gain since August. Subsequent consolidation between $12.62-$13.45 suggests new trading range forming.

Technical Positioning

  • Bullish Signals: MACD crossover + volume surge confirm momentum shift
  • Immediate Resistance: $13.45-13.62 area (recent highs & Bollinger upper band)
  • Critical Support: $12.02-12.62 zone (October rebound base)
  • Volume Profile: Sustained above-average trading since rebound (115k-141k vs 101k avg)

Fundamental Context

MetricValueImplication
ROE66.9%Exceptional capital efficiency
⚠️Debt/Equity559%Highly leveraged structure
🔻Revenue Growth-3.4%Contracting operations
📊P/E11.57Below healthcare sector average

Strategic Considerations

For Active Traders

  • Near-term upside to $13.62 (+1.4%) if momentum holds
  • Stop-loss prudent below $12.75 (recent consolidation low)
  • Watch for volume confirmation on breakout attempts

Longer-Term Investors

  • High debt load raises sustainability questions
  • Negative growth contrasts with strong ROE - warrants deeper due diligence
  • Sector outlook for health analytics remains favorable despite company-specific risks

Recommended Action Plan

  1. Day Traders: Scalp $13.15-13.45 range with tight stops
  2. Swing Traders: Consider long positions above $13.30 targeting $13.62 exit
  3. Risk-Averse Investors: Monitor debt management progress before entry

Data reflects market conditions as of November 3, 2025 closing. Past performance ≠ future results. Consult a financial advisor before trading. Volatility risk elevated with 52-week range of $9.76-$21.64.

KI-VorhersageBeta

KI-Empfehlung

Neutral

Aktualisiert am: 10. Nov. 2025, 13:54

BärischNeutralBullisch

65.2% Konfidenz

Risiko & Handel

Risikostufe4/5
Hohes Risiko
Geeignet für
Moderat
Handelsleitfaden

Einstiegspunkt

$14.43

Gewinnmitnahme

$15.02

Stop-Loss

$13.26

Schlüsselfaktoren

PDI 19.4 liegt über MDI 8.9 mit ADX 19.1, was auf einen bullischen Trend hindeutet
Aktueller Preis liegt nahe dem Unterstützungsniveau ($14.49), was auf eine potenzielle Kaufgelegenheit hindeutet
Handelsvolumen ist 2.3x Durchschnitt (1,578), was auf signifikantes Kaufinteresse hindeutet
MACD 0.0541 liegt über der Signallinie 0.0328, was auf einen bullischen Crossover hindeutet

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.